特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

COVID-19治療薬関連APIの世界市場 - COVID-19による成長と変化:2020年

COVID-19 Drug Associated APIs Global Market Report 2020: COVID 19 Growth and Change

発行 The Business Research Company 商品コード 950446
出版日 ページ情報 英文 200 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=107.57円で換算しております。
COVID-19治療薬関連APIの世界市場 - COVID-19による成長と変化:2020年 COVID-19 Drug Associated APIs Global Market Report 2020: COVID 19 Growth and Change
出版日: 2020年07月17日 ページ情報: 英文 200 Pages
概要

当レポートでは、世界のCOVID-19治療薬関連API市場について調査分析し、市場概要、市場規模と予測、セグメント別の市場分析、地域別の市場分析、競合情勢などについて、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 COVID-19治療薬関連API市場の特徴

第3章 COVID-19治療薬関連API市場規模と成長

  • 世界のCOVID-19治療薬関連API市場実績 (金額)
    • 市場促進要因
    • 市場抑制要因
  • 世界のCOVID-19治療薬関連API市場予測 (金額)
    • 市場促進要因
    • 市場抑制要因

第4章 COVID-19治療薬関連API市場セグメンテーション

  • 世界のCOVID-19治療薬関連API市場:薬剤分類別、実績と予測 (金額)
    • 抗マラリア薬
    • 気管支拡張薬
    • 抗生物質
    • 抗ウイルス薬
    • その他

第5章 COVID-19治療薬関連API市場の地域別・国別分析

  • 世界のCOVID-19治療薬関連API市場:地域別、実績と予測 (金額)
  • 世界のCOVID-19治療薬関連API市場:国別、実績と予測 (金額)

第6章 アジア太平洋のCOVID-19治療薬関連API市場

  • アジア太平洋のCOVID-19治療薬関連API市場概要
  • アジア太平洋のCOVID-19治療薬関連API市場:薬剤分類別、実績と予測 (金額)

第7章 中国のCOVID-19治療薬関連API市場

  • 中国のCOVID-19治療薬関連API市場概要
  • 中国のCOVID-19治療薬関連API市場:薬剤分類別、実績と予測 (金額)

第8章 インドのCOVID-19治療薬関連API市場

  • インドのCOVID-19治療薬関連API市場概要
  • インドのCOVID-19治療薬関連API市場:薬剤分類別、実績と予測 (金額)

第9章 日本のCOVID-19治療薬関連API市場

  • 日本のCOVID-19治療薬関連API市場概要
  • 日本のCOVID-19治療薬関連API市場:薬剤分類別、実績と予測 (金額)

第10章 オーストラリアのCOVID-19治療薬関連API市場

  • オーストラリアのCOVID-19治療薬関連API市場:薬剤分類別、実績と予測 (金額)

第11章 インドネシアのCOVID-19治療薬関連API市場

  • インドネシアのCOVID-19治療薬関連API市場:薬剤分類別、実績と予測 (金額)

第12章 韓国のCOVID-19治療薬関連API市場

  • 韓国のCOVID-19治療薬関連API市場:薬剤分類別、実績と予測 (金額)

第13章 西欧のCOVID-19治療薬関連API市場

  • 西欧のCOVID-19治療薬関連API市場概要
  • 西欧のCOVID-19治療薬関連API市場:薬剤分類別、実績と予測 (金額)

第14章 英国のCOVID-19治療薬関連API市場

  • 英国のCOVID-19治療薬関連API市場概要
  • 英国のCOVID-19治療薬関連API市場:薬剤分類別、実績と予測 (金額)

第15章 ドイツのCOVID-19治療薬関連API市場

  • ドイツのCOVID-19治療薬関連API市場:薬剤分類別、実績と予測 (金額)

第16章 フランスのCOVID-19治療薬関連API市場

  • フランスのCOVID-19治療薬関連API市場:薬剤分類別、実績と予測 (金額)

第17章 東欧のCOVID-19治療薬関連API市場

  • 東欧のCOVID-19治療薬関連API市場概要
  • 東欧のCOVID-19治療薬関連API市場:薬剤分類別、実績と予測 (金額)

第18章 ロシアのCOVID-19治療薬関連API市場

  • ロシアのCOVID-19治療薬関連API市場:薬剤分類別、実績と予測 (金額)

第19章 北米のCOVID-19治療薬関連API市場

  • 北米のCOVID-19治療薬関連API市場概要
  • 北米のCOVID-19治療薬関連API市場:薬剤分類別、実績と予測 (金額)

第20章 米国のCOVID-19治療薬関連API市場

  • 米国のCOVID-19治療薬関連API市場概要
  • 米国のCOVID-19治療薬関連API市場:薬剤分類別、実績と予測 (金額)

第21章 南米のCOVID-19治療薬関連API市場

  • 南米のCOVID-19治療薬関連API市場概要
  • 南米のCOVID-19治療薬関連API市場:薬剤分類別、実績と予測 (金額)

第22章 ブラジルのCOVID-19治療薬関連API市場

  • ブラジルのCOVID-19治療薬関連API市場:薬剤分類別、実績と予測 (金額)

第23章 中東のCOVID-19治療薬関連API市場

  • 中東のCOVID-19治療薬関連API市場概要
  • 中東のCOVID-19治療薬関連API市場:薬剤分類別、実績と予測 (金額)

第24章 アフリカのCOVID-19治療薬関連API市場

  • アフリカのCOVID-19治療薬関連API市場概要
  • アフリカのCOVID-19治療薬関連API市場:薬剤分類別、実績と予測 (金額)

第25章 COVID-19治療薬関連API市場の競合情勢と企業プロファイル

  • COVID-19治療薬関連API市場の競合情勢
  • COVID-19治療薬関連API市場の企業プロファイル
    • Dr. Reddy's Laboratories
    • Lianyungang Guike Pharmaceutical
    • Alembic Pharmaceutical
    • Wockhardt Ltd
    • Sandoz Srl

第26章 COVID-19治療薬関連API市場における主要なM&A

第27章 COVID-19治療薬関連API市場の動向と戦略

第28章 COVID-19治療薬関連API市場の将来見通しと潜在的分析

第29章 付録

目次

COVID-19 Drug Associated APIs Global Market Report 2020: COVID 19 Growth and Change from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global covid19 drug associated apis market.

This report focuses on covid19 drug associated apis market which is experiencing strong growth. The report gives a guide to the covid19 drug associated apis market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the covid19 drug associated apis? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The COVID19 Drug associated APIs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider covid19 drug associated apis market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID 19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The covid19 drug associated apis market section of the report gives context. It compares the covid19 drug associated apis market with other segments of the covid19 drug associated apis market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, covid19 drug associated apis indicators comparison.

Scope

Markets Covered:

1) By Drug Class: Antimalarials; Bronchodilators; Antibiotics; Antivirals; Others

Companies Mentioned: Dr. Reddy's Laboratories; Lianyungang Guike Pharmaceutical; Alembic Pharmaceutical; Wockhardt Ltd; Sandoz Srl

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. COVID19 Drug Associated APIs Market Characteristics

3. COVID19 Drug Associated APIs Market Size And Growth

  • 3.1. Global COVID19 Drug Associated APIs Historic Market, 2015 - 2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global COVID19 Drug Associated APIs Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. COVID19 Drug Associated APIs Market Segmentation

  • 4.1. Global COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Antimalarials
    • Bronchodilators
    • Antibiotics
    • Antivirals
    • Others

5. COVID19 Drug Associated APIs Market Regional And Country Analysis

  • 5.1. Global COVID19 Drug Associated APIs Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 5.2. Global COVID19 Drug Associated APIs Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific COVID19 Drug Associated APIs Market

  • 6.1. Asia-Pacific COVID19 Drug Associated APIs Market Overview
  • 6.2. Asia-Pacific COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China COVID19 Drug Associated APIs Market

  • 7.1. China COVID19 Drug Associated APIs Market Overview
  • 7.2. China COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India COVID19 Drug Associated APIs Market

  • 8.1. India COVID19 Drug Associated APIs Market Overview
  • 8.2. India COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan COVID19 Drug Associated APIs Market

  • 9.1. Japan COVID19 Drug Associated APIs Market Overview
  • 9.2. Japan COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia COVID19 Drug Associated APIs Market

  • 10.1. Australia COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia COVID19 Drug Associated APIs Market

  • 11.1. Indonesia COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea COVID19 Drug Associated APIs Market

  • 12.1. South Korea COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe COVID19 Drug Associated APIs Market

  • 13.1. Western Europe COVID19 Drug Associated APIs Market Overview
  • 13.2. Western Europe COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK COVID19 Drug Associated APIs Market

  • 14.1. UK COVID19 Drug Associated APIs Market Overview
  • 14.2. UK COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany COVID19 Drug Associated APIs Market

  • 15.1. Germany COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France COVID19 Drug Associated APIs Market

  • 16.3. France COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe COVID19 Drug Associated APIs Market

  • 17.1. Eastern Europe COVID19 Drug Associated APIs Market Overview
  • 17.2. Eastern Europe COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia COVID19 Drug Associated APIs Market

  • 18.1. Russia COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America COVID19 Drug Associated APIs Market

  • 19.1. North America COVID19 Drug Associated APIs Market Overview
  • 19.2. North America COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA COVID19 Drug Associated APIs Market

  • 20.1. USA COVID19 Drug Associated APIs Market Overview
  • 20.2. USA COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America COVID19 Drug Associated APIs Market

  • 21.1. South America COVID19 Drug Associated APIs Market Overview
  • 21.2. South America COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil COVID19 Drug Associated APIs Market

  • 22.1. Brazil COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East COVID19 Drug Associated APIs Market

  • 23.1. Middle East COVID19 Drug Associated APIs Market Overview
  • 23.2. Middle East COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa COVID19 Drug Associated APIs Market

  • 24.1. Africa COVID19 Drug Associated APIs Market Overview
  • 24.2. Africa COVID19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. COVID19 Drug Associated APIs Market Competitive Landscape And Company Profiles

  • 25.1. COVID19 Drug Associated APIs Market Competitive Landscape
  • 25.2. COVID19 Drug Associated APIs Market Company Profiles
    • 25.2.1. Dr. Reddy's Laboratories
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. Lianyungang Guike Pharmaceutical
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Alembic Pharmaceutical
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Wockhardt Ltd
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Sandoz Srl
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The COVID19 Drug Associated APIs Market

27. COVID19 Drug Associated APIs Market Trends And Strategies

28. COVID19 Drug Associated APIs Market Future Outlook and Potential Analysis

29. Appendix

  • 29.1. Abbreviations
  • 29.2. Currencies
  • 29.3. Research Inquiries
  • 29.4. The Business Research Company
  • 29.5. Copyright And Disclaimer